Apellis Pharmaceuticals, Inc. (APLS): 15-12G filed May 26, 2026

Form type

15-12G

Filing date

May 26, 2026

Accession number

0000950157-26-000636

Filer

Apellis Pharmaceuticals, Inc. (CIK 1492422)